EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis

Charlotte Birner, Patricia Mester, Gerhard Liebisch iD, Marcus Höring iD, Stephan Schmid iD, Martina Müller, Vlad Pavel iD, Christa Buechler iD

Infectious Disease Reports · 26.08.2024 · 16 (5) · 806-819

DOI: 10.3390/idr16050062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infectious Disease Reports, online erschienen am 26.08.2024. Verfasst von Charlotte Birner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg…. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Critical illness causes disturbances in lipid metabolism. Here, we investigated the levels of apolipoprotein A-IV (apoA-IV), a regulator of triglyceride and cholesterol metabolism, in human sepsis. ApoA-IV (analyzed in 156 patients with systemic inflammatory response syndrome (SIRS)/sepsis) and cholesteryl ester (CE) (analyzed in 121 of these patients) were lower in patients compared to 43 healthy controls. In contrast, triglyceride (TG) levels were elevated in patients. ApoA-IV levels in plasma of the patients did not correlate with these lipids. Patients with SIRS, sepsis or septic shock had comparable apoA-IV, TG, CE and free cholesterol (FC) levels. Patients on dialysis had significantly lower CE levels, whereas apoA-IV levels did not change much. CE levels were elevated in patients with viral sepsis due to SARS-CoV-2 infection in comparison to SIRS/sepsis patients not infected by this virus. CE levels correlated negatively with procalcitonin, interleukin-6 and bilirubin, while TGs were positively associated with bilirubin and C-reactive protein. ApoA-IV, TG, CE and FC levels were not associated with bacterial infection or survival. In conclusion, this analysis suggests that CE levels decline in sepsis-related renal failure and also shows that plasma apoA-IV and CE levels are early biomarkers of sepsis.

Schlagwörter

Stichwörter der Autor:innen

apolipoproteincholesterolseptic shocksurvivaltriglyceride

Autor:innen und Institutionen

  • Department of Internal Medicine I, Gastroenterology, Hepatology, Endocrinology, Rheumatology, and Infectious Diseases, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Institute of Clinical Chemistry and Laboratory Medicine, Regensburg University Hospital, 93053 Regensburg, Germany.

ORCID-Profile: Gerhard Liebisch, Marcus Höring, Stephan Schmid, Vlad Pavel, Christa Buechler

Zitieren

APA

Birner, C., Mester, P., Liebisch, G., Höring, M., Schmid, S., Müller, M., Pavel, V., & Buechler, C. (2024). Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis. Infectious Disease Reports, 16(5), 806-819. https://doi.org/10.3390/idr16050062

Vancouver

Birner C, Mester P, Liebisch G, Höring M, Schmid S, Müller M, et al. Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis. Infectious Disease Reports. 2024;16(5):806-819. doi:10.3390/idr16050062

BibTeX
@article{Birner2024,
  author = {Birner, Charlotte and Mester, Patricia and Liebisch, Gerhard and Höring, Marcus and Schmid, Stephan and Müller, Martina and Pavel, Vlad and Buechler, Christa},
  title = {Lipid Metabolism Disorders as Diagnostic Biosignatures in Sepsis},
  journal = {Infectious Disease Reports},
  year = {2024},
  volume = {16},
  number = {5},
  pages = {806--819},
  doi = {10.3390/idr16050062}
}
Kostenlos starten →